PARKINInactivation Links Parkinson’s Disease to Melanoma

Loss of Heterozygosity and Copy Number Abnormality in Clear Cell Renal Cell Carcinoma Discovered by High-Density Affymetrix 10K Single Nucleotide Polymorphism Mapping Array

(2015) Marieta I. Toma et al.   NEOPLASIA

Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins

(2014) Yongxing Gong et al.   NATURE GENETICS

Parkin deficiency contributes to pancreatic tumorigenesis by inducing spindle multipolarity and misorientation

(2013) Xiaodong Sun et al.   CELL CYCLE

Parkin Pathway Activation Mitigates Glioma Cell Proliferation and Predicts Patient Survival

(2012) C. W. S. Yeo et al.   CANCER RESEARCH

Malignant melanoma, breast cancer and other cancers in patients with Parkinson's disease

(2012) Kathrine Rugbjerg et al.   INTERNATIONAL JOURNAL OF CANCER

The association between Parkinson's disease and melanoma

(2011) Tianhong Pan et al.   INTERNATIONAL JOURNAL OF CANCER

High prevalence of malignant melanoma in Israeli patients with Parkinson’s disease

(2011) R. Inzelberg et al.   JOURNAL OF NEURAL TRANSMISSION

ERK and PDE4 cooperate to induce RAF isoform switching in melanoma

(2011) Amélie Marquette et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Meta-analysis of the relationship between Parkinson disease and melanoma

(2011) R. Liu et al.   NEUROLOGY

Increased Melanoma Risk in Parkinson Disease

(2010) John M. Bertoni   ARCHIVES OF NEUROLOGY

Somatic alterations in the melanoma genome: A high-resolution array-based comparative genomic hybridization study

(2010) Andreas Gast et al.   GENES CHROMOSOMES & CANCER

Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update

(2010) Karen Nuytemans et al.   HUMAN MUTATION

Parkinson's Disease and Cancer: The Unexplored Connection

(2010) K. Garber   JNCI-Journal of the National Cancer Institute

A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2

(2010) D. M. Kay et al.   NEUROLOGY

PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice

(2010) G. Poulogiannis et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human malignancies

(2009) Selvaraju Veeriah et al.   NATURE GENETICS

Parkin is recruited selectively to impaired mitochondria and promotes their autophagy

(2008) Derek Narendra et al.   JOURNAL OF CELL BIOLOGY